Pharmacy Purchasing & Products Magazine FDA to Convene Pharmacy Compounding Advisory Committee in July Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Poised to Ease Restrictions on Injectable Peptides Af